United States · Wires & real time · PR Newswire
LUNGevity Invests $1M+ in High-Priority Research to Expand Lung Cancer Workforce & Improve Patient Care
New awards support research spanning early detection, immunotherapy resistance, predictive biomarkers, and personalized treatment WASHINGTON, Oct. 28, 2026 /PRNewswire/ --…
Read the full article on PR Newswire Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.prnewswire.com)
